small molecule

LUMASON

SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

Loss of exclusivityMay 2039latest FDA-listed patent expiry
CompanyBRACCO DIAGNOSTICS INC

Drug detail

Brand nameLUMASON
Active ingredientSULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES
Strength60.7MG/25MG
Dosage formFOR SUSPENSION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalOctober 2014
Marketing statusRX

Listed patents

PatentExpiresType
11723869May 2039product
10232061July 2038product
10335502July 2038product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LUMASON patent cliff — loss of exclusivity May 2039 | CliffBio